167 related articles for article (PubMed ID: 16234827)
21. The G2 chromosomal radiosensitivity assay.
Bryant PE; Gray L; Riches AC; Steel CM; Finnon P; Howe O; Kesterton I; Vral A; Curwen GB; Smart V; Tawn EJ; Whitehouse CA
Int J Radiat Biol; 2002 Sep; 78(9):863-6. PubMed ID: 12428927
[TBL] [Abstract][Full Text] [Related]
22. Chromosomal radiosensitivity in G2-phase lymphocytes as an indicator of cancer predisposition.
Scott D; Spreadborough AR; Jones LA; Roberts SA; Moore CJ
Radiat Res; 1996 Jan; 145(1):3-16. PubMed ID: 8532833
[TBL] [Abstract][Full Text] [Related]
23. G2 chromosomal radiosensitivity in fibroblasts of ataxia-telangiectasia heterozygotes and a Li-Fraumeni syndrome patient with radioresistant cells.
Mitchell EL; Scott D
Int J Radiat Biol; 1997 Oct; 72(4):435-8. PubMed ID: 9343108
[TBL] [Abstract][Full Text] [Related]
24. Chromosomal radiosensitivity during the G2 cell-cycle period of skin fibroblasts from individuals with familial cancer.
Parshad R; Sanford KK; Jones GM
Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5400-3. PubMed ID: 3860870
[TBL] [Abstract][Full Text] [Related]
25. Modulation of radiation-induced chromosomal damage by inhibitors of DNA repair and flow cytometric analysis in ataxia telangiectasia cells with 'intermediate radiosensitivity'.
Antoccia A; Chessa L; Ricordy R; Tanzarella C
Mutagenesis; 1995 Nov; 10(6):523-9. PubMed ID: 8596472
[TBL] [Abstract][Full Text] [Related]
26. Elevated G2 chromosomal radiosensitivity in Irish breast cancer patients: a comparison with other studies.
Howe OL; Daly PA; Seymour C; Ormiston W; Nolan C; Mothersill C
Int J Radiat Biol; 2005 May; 81(5):373-8. PubMed ID: 16076752
[TBL] [Abstract][Full Text] [Related]
27. Topoisomerase IIα levels and G2 radiosensitivity in T-lymphocytes of women presenting with breast cancer.
Bryant PE; Riches AC; Shovman O; Dewar JA; Adamson DJ
Mutagenesis; 2012 Nov; 27(6):737-41. PubMed ID: 22935224
[TBL] [Abstract][Full Text] [Related]
28. Chromosomal radiosensitivity in breast cancer patients: influence of age of onset of the disease.
Baeyens A; Van Den Broecke R; Makar A; Thierens H; De Ridder L; Vral A
Oncol Rep; 2005 Feb; 13(2):347-53. PubMed ID: 15643523
[TBL] [Abstract][Full Text] [Related]
29. Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer.
Barber JB; Burrill W; Spreadborough AR; Levine E; Warren C; Kiltie AE; Roberts SA; Scott D
Radiother Oncol; 2000 May; 55(2):179-86. PubMed ID: 10799730
[TBL] [Abstract][Full Text] [Related]
30. G2 Chromosomal Radiosensitivity Assay for Testing Individual Radiation Sensitivity.
Haskins JS; Kato TA
Methods Mol Biol; 2019; 1984():39-45. PubMed ID: 31267418
[TBL] [Abstract][Full Text] [Related]
31. Relationships between clonogenic cell survival, DNA damage and chromosomal radiosensitivity in nine human cervix carcinoma cell lines.
Eastham AM; Atkinson J; West CM
Int J Radiat Biol; 2001 Mar; 77(3):295-302. PubMed ID: 11258843
[TBL] [Abstract][Full Text] [Related]
32. Less G(2) arrest in irradiated cells of breast cancer patients than in female controls: a contribution to their enhanced chromosomal radiosensitivity?
Scott D; Spreadborough AR; Roberts SA
Int J Radiat Biol; 2003 Jun; 79(6):405-11. PubMed ID: 12963542
[TBL] [Abstract][Full Text] [Related]
33. Chromosomal aberrations and in vitro radiosensitivity: intra-individual versus inter-individual variability.
Vral A; Thierens H; Baeyens A; De Ridder L
Toxicol Lett; 2004 Apr; 149(1-3):345-52. PubMed ID: 15093280
[TBL] [Abstract][Full Text] [Related]
34. Chromosomal abnormalities among offspring of childhood-cancer survivors in Denmark: a population-based study.
Winther JF; Boice JD; Mulvihill JJ; Stovall M; Frederiksen K; Tawn EJ; Olsen JH
Am J Hum Genet; 2004 Jun; 74(6):1282-5. PubMed ID: 15106125
[TBL] [Abstract][Full Text] [Related]
35. Chromosomal radiosensitivity analyzed by FISH in lymphocytes of prostate cancer patients and healthy donors.
Schmitz S; Brzozowska K; Pinkawa M; Eble M; Kriehuber R
Radiat Res; 2013 Nov; 180(5):465-73. PubMed ID: 24083681
[TBL] [Abstract][Full Text] [Related]
36. Relationship between individual radiosensitivity and radiation encephalopathy of nasopharyngeal carcinoma after radiotherapy.
Tang Y; Zhang Y; Guo L; Peng Y; Luo Q; Xing Y
Strahlenther Onkol; 2008 Oct; 184(10):510-4. PubMed ID: 19016039
[TBL] [Abstract][Full Text] [Related]
37. Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays.
Scott D; Barber JB; Spreadborough AR; Burrill W; Roberts SA
Int J Radiat Biol; 1999 Jan; 75(1):1-10. PubMed ID: 9972785
[TBL] [Abstract][Full Text] [Related]
38. Chromosomal radiosensitivity and acute radiation side effects after radiotherapy in tumour patients--a follow-up study.
Huber R; Braselmann H; Geinitz H; Jaehnert I; Baumgartner A; Thamm R; Figel M; Molls M; Zitzelsberger H
Radiat Oncol; 2011 Apr; 6():32. PubMed ID: 21473753
[TBL] [Abstract][Full Text] [Related]
39. The radiosensitizing potential of glutaraldehyde on MCF7 breast cancer cells as quantified by means of the G2-chromosomal radiosensitivity assay.
Hatzi VI; Terzoudi GI; Barszczewska K; Makropoulos V; Pantelias GE
Mol Biol Rep; 2012 Jan; 39(1):251-7. PubMed ID: 21556769
[TBL] [Abstract][Full Text] [Related]
40. The use of EBV-transformed cell lines of breast cancer patients to measure chromosomal radiosensitivity.
Baeyens A; Thierens H; Vandenbulcke K; De Ridder L; Vral A
Mutagenesis; 2004 Jul; 19(4):285-90. PubMed ID: 15215327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
